Menu
  • Join
  • Login
  • Contact
 

Search abstracts


BIOSIMILARS: REGULATORY ASPECTS IN THE USA AND THE EU

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: KHALID, Garba Mohammed (Università degli Studi di Milano, Department of Pharmaceutical Sciences, Italy)
  • Co-author(s): Garba Mohammed Khalid: Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy
    Paolo Rocco: Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy
    Paola Minghetti: Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy
  • Abstract:

    Background

    The high cost of biotechnological medicinal products and the increasing number of patent and data protection expirations is motivating manufacturers to develop biosimilar products and physicians to prescribe them, either spontaneously or due to payers’ policies (non-medical switch or constrained prescription). Unlike generics, biosimilars

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses